Lycopodium Limited
LYOPF · OTC
6/30/2025 | 12/30/2024 | 6/30/2024 | 12/30/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 1.3% | -2.3% | -2.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 152.8% | 30.7% | 20.8% | 25.5% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 17.9% | 22.7% | 18.7% | 24.4% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 10.1% | 15.2% | 12.2% | 17.1% |
| EPS Diluted | 0.42 | 0.64 | 0.53 | 0.77 |
| % Growth | -34.4% | 20.8% | -31.2% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |